CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY

dc.authoridDolarslan, Murside Esra/0000-0002-8669-4212
dc.authoridARICI, MUSTAFA/0000-0002-4055-7896
dc.authoridkoyuncu, sumeyra/0000-0002-1159-5818
dc.authoridKarahisar Şirali, Semahat/0000-0003-0981-8928
dc.authoridSahin, Idris/0000-0002-8683-3737
dc.authoridBakirdogen, Serkan/0000-0002-3448-0490
dc.authoridArtan, Ayse/0000-0002-6461-3178
dc.authorwosidDolarslan, Murside Esra/D-5535-2019
dc.authorwosidARICI, MUSTAFA/I-9265-2013
dc.authorwosidkoyuncu, sumeyra/HOH-4247-2023
dc.authorwosidKarahisar Şirali, Semahat/AHC-1920-2022
dc.authorwosidSahin, Idris/AAS-4390-2020
dc.authorwosidBakirdogen, Serkan/ABI-3906-2020
dc.authorwosidArtan, Ayse/AAK-7036-2020
dc.contributor.authorGursu, Meltem
dc.contributor.authorOzturk, Savas
dc.contributor.authorArici, Mustafa
dc.contributor.authorSahin, Idris
dc.contributor.authorGoekcay Bek, Sibel
dc.contributor.authorYilmaz, Murvet
dc.contributor.authorKoyuncu, Sumeyra
dc.date.accessioned2024-08-04T20:53:08Z
dc.date.available2024-08-04T20:53:08Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome.Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded.Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis.Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.en_US
dc.identifier.doi10.1159/000526909
dc.identifier.endpage615en_US
dc.identifier.issn1420-4096
dc.identifier.issn1423-0143
dc.identifier.issue10en_US
dc.identifier.pmid36099904en_US
dc.identifier.scopus2-s2.0-85141894034en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage605en_US
dc.identifier.urihttps://doi.org/10.1159/000526909
dc.identifier.urihttps://hdl.handle.net/11616/100991
dc.identifier.volume47en_US
dc.identifier.wosWOS:000856925300001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofKidney & Blood Pressure Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMortalityen_US
dc.titleCHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDYen_US
dc.typeArticleen_US

Dosyalar